Research programme: nicotinamide phosphoribosyltransferase modulators - Calico

Drug Profile

Research programme: nicotinamide phosphoribosyltransferase modulators - Calico

Alternative Names: NAMPT modulators - Calico; P7C3 aminopropyl carbazloes - Calico

Latest Information Update: 17 Sep 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator University of Texas Southwestern Medical Center
  • Developer Calico
  • Class Carbazoles
  • Mechanism of Action Nicotinamide phosphoribosyltransferase modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Neurodegenerative disorders

Most Recent Events

  • 11 Sep 2014 Calico in-licenses NAMPT modulators from 2M Companies
  • 11 Sep 2014 Preclinical trials in Neurodegenerative disorders in USA before September 2014 (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top